The increased advancements in NGS platforms, a decrease in the price of sequencing, and improving the NGS-based diagnostic test reimbursement scenario are driving the demand for the market.
According to a recent analysis by Emergen Research, the global market for next-generation sequencing (NGS) sample preparation is anticipated to reach USD 6,630.0 Million by 2027. One of the key aspects driving the growth of the NGS sample preparation industry is the numerous benefits of high-performance sequencing over genetics-related technologies like microarray and sanger-seq. Additionally, it is predicted that the availability of sample methods with less DNA input will lower total costs, increasing the usage of next-generation sequencing in a variety of academic and medical settings.
This market has grown as a result of a number of factors, including the falling cost of sequencing, the availability of advanced and cost-effective NGS platforms, the expansion of NGS applications in a variety of industries, including diagnostics, agro-genomics, animal research, and drug and biomarker discovery, the rise in sequencing-intensive research, and the availability of research grants (which are driving the adoption of NGS).
Due to the increasing frequency of infectious diseases around the world, the therapeutic area category for infectious diseases is anticipated to experience the quickest market growth during the forecast period. The next-generation sequencing aids in the diagnosis of serious infectious disorders, in particular those brought on by combined infections. Many different samples must be sent to labs in order to lessen the burden of infectious diseases.
A complete strategy for identifying infectious diseases may now be developed thanks to advancements in next-generation sequencing technology. New viruses and disorders that are resistant to traditional testing have been screened for and diagnosed using NGS. The method allows for universal and unbiased pathogen identification by continuously improving and recognising every pathogen that might be present in a sample. The use of NGS equipment and supplies in general, including those used for specimen preparation, has increased as a result of this.
Key Highlights:
The market is divided into workstations and reagents & consumables based on product. Based on workflow, the reagents & consumables category is further divided into library preparation, target enrichment, and quality control. This market has grown as a result of a number of factors, including the falling cost of sequencing, the availability of advanced and cost-effective NGS platforms, the expansion of NGS applications in a variety of industries, including diagnostics, agro-genomics, animal research, and drug and biomarker discovery, the rise in sequencing-intensive research, and the availability of research grants (which are driving the adoption of NGS).
The market is divided into diagnostics, drug discovery, agricultural & animal research, and other applications based on application. Due to the increasing number of new cancer cases worldwide, the favourable reimbursement environment for NGS-based tests in the US, and the growing attention of key market players on developing NGS-based products & services for cancer and NIPT, the diagnostics segment is anticipated to hold the largest share of the market.
The largest revenue-producing region in the worldwide NGS sample preparation market is North America. The significant market share of this region can be mainly attributed to the encouraging initiatives by government and private bodies for the development and adoption of NGS technologies, the widespread adoption of NGS diagnostics in the region, the rising number of NGS-based research & clinical applications in the region, the expansion of cancer research, the rising awareness of NGS services, and the presence of top NGS service providers.
Key participants include Agilent Technologies, Bio-Rad Laboratories, Inc., BGI; Biomatters Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd., Genomatix GmbH, Thermo Fisher Scientific, and Foundation Medicine, among others, among others.
Emergen Research has segmented the global next generation sequencing (NGS) sample preparation market on the basis of workflow, application, end-users, and region:
Workflow Outlook (Revenue, USD Billion; 2017-2027)
- NGS Library Preparation Kit
- Semi-Automated Library Preparation
- Automated Library Preparation
- Colonial Amplification
Application Outlook (Revenue, USD Billion; 2017-2027)
- Oncology
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology, & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
